이 웹사이트는 쿠키를 사용하여 장치에 정보를 저장합니다. 쿠키는 당사 웹 사이트의 정상적인 작동을 도와주고 사용자 경험을 개선 할 수 있는 방법을 보여줍니다.

사이트를 계속 사용하는 경우, 쿠키 정책 및 개인 정보 보호 정책에 동의하는 것으로 간주됩니다.

Hikvision’s new business team to develop intelligent solutions for fentanyl-related substances regulation

Hikvision, the world’s leading supplier of innovative video surveillance products and solutions, has announced a new business team dedicated towards developing intelligent solutions for fentanyl-related substances regulation. This is a solid move to respond and contribute to the joint efforts between the governments of China and the U.S., together with the international community, to combat drug crimes and protect the public health and safety. Relying on Hikvision’s advanced video technology and big data analytics, the new dedicated team will be committed to develop intelligent solutions for fentanyl regulation.

 

In recent years, how to effectively regulate and control the new types of psychoactive substances, including fentanyl, has become a serious international problem. In late 2018, the leaders and governments of China and the U.S. reached an agreement on cooperation in law enforcement and Fentanyl control. Recently, China’s Ministry of Public Security, National Health Commission, and National Medical Products Administration jointly announced to regulate all fentanyl-related substances as a class of controlled substances (with non-medical use), which takes effective May 1, 2019.

 

Due to its numerous variants and low threshold for synthesis, Fentanyl has put forward a new challenge to the technology of drug inspection and control. The new dedicated team of Hikvision is composed of experts in many fields like system architecture, central platform, algorithms and products. With experience in intelligent video applications and big data analytics, the team will conduct in-depth research on key technical issues existing in production, storage and transportation of Fentanyl, and develop customized intelligent solutions for optimization of drug control.

 

Mr. Cai Changyang, Senior VP of Hikvision, said: "Creating more value to the society through our advanced technology has always been the goal Hikvision pursued. The problem of new types of drugs, including fentanyl-related substances has caused risks and hazards worldwide. Therefore, the company has decided to set up the dedicated team to respond to the challenges and to join the joint endeavor, aiming to make contributions to protect the physical and mental health of people, as well as safeguard our communities and society. "